First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Clinical trial NCT04000282 · COMPLETED

Trial details

NCT number: NCT04000282
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2019-08-19
Primary completion: 2022-08-29
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.